Rigel Pharmaceuticals Current Ratio 2006-2020 | RIGL

Rigel Pharmaceuticals current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Rigel Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.12B $0.03B 3.73
2019-12-31 $0.12B $0.06B 2.04
2019-09-30 $0.13B $0.03B 4.06
2019-06-30 $0.13B $0.03B 4.39
2019-03-31 $0.14B $0.03B 5.33
2018-12-31 $0.14B $0.03B 4.94
2018-09-30 $0.12B $0.02B 6.15
2018-06-30 $0.14B $0.02B 8.01
2018-03-31 $0.10B $0.02B 5.14
2017-12-31 $0.12B $0.02B 6.40
2017-09-30 $0.07B $0.02B 4.64
2017-06-30 $0.08B $0.02B 5.28
2017-03-31 $0.10B $0.02B 5.77
2016-12-31 $0.08B $0.02B 3.37
2016-09-30 $0.09B $0.02B 4.20
2016-06-30 $0.10B $0.02B 4.40
2016-03-31 $0.11B $0.03B 3.81
2015-12-31 $0.13B $0.03B 3.82
2015-09-30 $0.14B $0.04B 3.91
2015-06-30 $0.15B $0.03B 4.26
2015-03-31 $0.16B $0.03B 4.73
2014-12-31 $0.15B $0.01B 10.73
2014-09-30 $0.16B $0.01B 15.58
2014-06-30 $0.18B $0.01B 17.64
2014-03-31 $0.20B $0.01B 25.15
2013-12-31 $0.22B $0.01B 21.38
2013-09-30 $0.23B $0.01B 28.06
2013-06-30 $0.26B $0.01B 30.05
2013-03-31 $0.28B $0.01B 30.07
2012-12-31 $0.30B $0.01B 24.78
2012-09-30 $0.19B $0.01B 17.63
2012-06-30 $0.21B $0.01B 21.72
2012-03-31 $0.23B $0.01B 28.12
2011-12-31 $0.25B $0.01B 21.71
2011-09-30 $0.27B $0.01B 31.89
2011-06-30 $0.28B $0.01B 36.30
2011-03-31 $0.16B $0.01B 22.50
2010-12-31 $0.18B $0.01B 15.89
2010-09-30 $0.20B $0.01B 15.05
2010-06-30 $0.19B $0.06B 3.05
2010-03-31 $0.21B $0.12B 1.84
2009-12-31 $0.14B $0.02B 7.65
2009-09-30 $0.16B $0.02B 7.84
2009-06-30 $0.08B $0.02B 4.23
2009-03-31 $0.11B $0.02B 5.48
2008-12-31 $0.14B $0.02B 5.72
2008-09-30 $0.16B $0.02B 7.31
2008-06-30 $0.19B $0.02B 11.59
2008-03-31 $0.21B $0.01B 18.15
2007-12-31 $0.11B $0.02B 6.90
2007-09-30 $0.12B $0.01B 14.12
2007-06-30 $0.13B $0.01B 17.53
2007-03-31 $0.09B $0.01B 10.40
2006-12-31 $0.11B $0.01B 9.61
2006-09-30 $0.12B $0.01B 11.08
2006-06-30 $0.13B $0.01B 9.87
2006-03-31 $0.13B $0.02B 6.61
2005-12-31 $0.14B $0.02B 6.03
2005-09-30 $0.13B $0.02B 8.70
2005-06-30 $0.06B $0.02B 4.11
2005-03-31 $0.08B $0.02B 5.09
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.325B $0.059B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.703B 37.29
Takeda Pharmaceutical (TAK) Japan $60.564B 10.61
Astellas Pharma (ALPMY) Japan $34.792B 17.38
Eisai (ESALY) Japan $23.464B 43.71
UCB SA (UCBJF) Belgium $19.548B 0.00
Merck (MKGAF) Germany $15.238B 19.98
Grifols, S.A (GRFS) Spain $13.538B 16.83
Catalent (CTLT) United States $11.871B 45.89
Neurocrine Biosciences (NBIX) United States $11.460B 52.96
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $7.919B 42.10
Orion OYJ (ORINY) Finland $7.628B 34.18
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.623B 0.00
IPSEN SA ADR (IPSEY) France $6.744B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.605B 10.57
United Therapeutics (UTHR) United States $5.294B 10.03
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Evotec AG (EVTCY) Germany $4.079B 65.79
Nektar Therapeutics (NKTR) United States $3.850B 0.00
Hypermarcas (HYPMY) Brazil $3.838B 11.67
ChemoCentryx (CCXI) United States $3.771B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.390B 370.11
PTC Therapeutics (PTCT) United States $3.111B 0.00
FibroGen (FGEN) United States $2.998B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.617B 10.76
Cronos Group (CRON) Canada $2.309B 66.20
Pacira BioSciences (PCRX) United States $1.878B 38.43
Sage Therapeutics (SAGE) United States $1.829B 0.00
USANA Health Sciences (USNA) United States $1.810B 18.57
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.769B 0.00
Corcept Therapeutics (CORT) United States $1.737B 17.23
Xencor (XNCR) United States $1.736B 0.00
Heron Therapeutics (HRTX) United States $1.697B 0.00
Zogenix (ZGNX) United States $1.636B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.614B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.550B 11.86
Akebia Therapeutics (AKBA) United States $1.455B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.425B 15.35
Portola Pharmaceuticals (PTLA) United States $1.402B 0.00
Karyopharm Therapeutics (KPTI) United States $1.252B 0.00
Tilray (TLRY) Canada $1.252B 0.00
Translate Bio (TBIO) United States $1.242B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.162B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.014B 45.24
Indivior (INVVY) United States $0.957B 11.87
Endo (ENDP) Ireland $0.877B 1.36
ImmunoGen (IMGN) United States $0.858B 0.00
Collegium Pharmaceutical (COLL) United States $0.729B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.724B 0.00
Molecular Templates (MTEM) United States $0.713B 0.00
Aerie Pharmaceuticals (AERI) United States $0.679B 0.00
Trillium Therapeutics (TRIL) Canada $0.648B 0.00
Ardelyx (ARDX) United States $0.637B 0.00
Radius Health (RDUS) United States $0.609B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.530B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.519B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
DURECT (DRRX) United States $0.480B 0.00
Siga Technologies (SIGA) United States $0.468B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.462B 11.18
Harpoon Therapeutics (HARP) United States $0.457B 0.00
MEI Pharma (MEIP) United States $0.444B 0.00
Flexion Therapeutics (FLXN) United States $0.438B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.433B 16.90
Organogenesis Holdings (ORGO) United States $0.418B 0.00
Calithera Biosciences (CALA) United States $0.408B 0.00
Ocular Therapeutix (OCUL) United States $0.381B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.353B 0.00
TherapeuticsMD (TXMD) United States $0.323B 0.00
Lannett Co Inc (LCI) United States $0.314B 6.89
Avadel Pharmaceuticals (AVDL) Ireland $0.300B 0.00
Concert Pharmaceuticals (CNCE) United States $0.289B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
CASI Pharmaceuticals (CASI) United States $0.266B 0.00
Rafael Holdings (RFL) United States $0.259B 0.00
Redhill Biopharma (RDHL) Israel $0.250B 0.00
OptiNose (OPTN) United States $0.213B 0.00
VAXART, INC (VXRT) United States $0.206B 0.00
PROFOUND MEDICL (PROF) Canada $0.206B 0.00
Taiwan Liposome (TLC) Taiwan $0.200B 0.00
KalVista Pharmaceuticals (KALV) United States $0.194B 0.00
Xeris Pharmaceuticals (XERS) United States $0.192B 0.00
Jounce Therapeutics (JNCE) United States $0.189B 4.52
IMV INC (IMV) Canada $0.188B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 23.97
Aquestive Therapeutics (AQST) United States $0.178B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.176B 0.00
Altimmune (ALT) United States $0.134B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.124B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.119B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.109B 0.00
Recro Pharma (REPH) United States $0.107B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.103B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.101B 0.00
Sundial Growers (SNDL) Canada $0.092B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.089B 0.00
CTI BioPharma (CTIC) United States $0.088B 0.00
CV Sciences (CVSI) United States $0.085B 0.00
Otonomy (OTIC) United States $0.083B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.081B 0.00
Hemispherx BioPharma (AIM) United States $0.081B 0.00
SCYNEXIS (SCYX) United States $0.081B 0.00
Heat Biologics (HTBX) United States $0.078B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.077B 0.00
Onconova Therapeutics (ONTX) United States $0.074B 0.00
Nivalis Therapeutics (ALPN) United States $0.072B 0.00
Biomerica (BMRA) United States $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
MediWound (MDWD) Israel $0.055B 0.00
Aclaris Therapeutics (ACRS) United States $0.055B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 31.27
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
GTx (ONCT) United States $0.048B 0.00
IsoRay (ISR) United States $0.047B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 100.09
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
Lipocine (LPCN) United States $0.044B 0.00
AgeX Therapeutics (AGE) United States $0.040B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 7.23
Adamis Pharmaceuticals (ADMP) United States $0.037B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Novan (NOVN) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00